SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-029108
Filing Date
2024-06-20
Accepted
2024-06-20 16:03:29
Documents
14
Period of Report
2024-06-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K crdf-20240620.htm   iXBRL 8-K 57266
5 crdf-20240620_g1.jpg GRAPHIC 2732
  Complete submission text file 0001628280-24-029108.txt   185146

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crdf-20240620.xsd EX-101.SCH 1925
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crdf-20240620_lab.xml EX-101.LAB 20770
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crdf-20240620_pre.xml EX-101.PRE 12001
17 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20240620_htm.xml XML 2607
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 241056155
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)